| Primary |
| Fungal Infection |
62.5% |
| Vulvovaginal Mycotic Infection |
15.3% |
| Product Used For Unknown Indication |
4.2% |
| Hypertension |
2.8% |
| Vaginal Infection |
2.8% |
| Vulvovaginal Pruritus |
2.8% |
| Antacid Therapy |
1.4% |
| Back Pain |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Hypothyroidism |
1.4% |
| Swelling |
1.4% |
| Vulvovaginal Dryness |
1.4% |
| Yeast Infection |
1.4% |
|
| Vulvovaginal Pruritus |
16.0% |
| Vulvovaginal Burning Sensation |
10.0% |
| Application Site Pain |
6.0% |
| Burning Sensation |
6.0% |
| Pain |
6.0% |
| Pruritus |
6.0% |
| Swelling |
6.0% |
| Urticaria |
6.0% |
| Vulvovaginal Discomfort |
6.0% |
| Application Site Pruritus |
4.0% |
| Crying |
4.0% |
| Genital Swelling |
4.0% |
| Hypersensitivity |
4.0% |
| Vulvovaginal Pain |
4.0% |
| Abdominal Pain |
2.0% |
| Application Site Inflammation |
2.0% |
| Application Site Irritation |
2.0% |
| Application Site Swelling |
2.0% |
| Application Site Vesicles |
2.0% |
| Drug Ineffective |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
75.3% |
| Fungal Infection |
10.2% |
| Hypertension |
2.4% |
| Vaginal Infection |
2.4% |
| Antacid Therapy |
1.8% |
| Back Pain |
1.8% |
| Vulvovaginal Dryness |
1.8% |
| Hypothyroidism |
1.2% |
| Atrial Fibrillation |
0.6% |
| Burning Sensation |
0.6% |
| Micturition Disorder |
0.6% |
| Post Coital Contraception |
0.6% |
| Vulvovaginal Pruritus |
0.6% |
|
| Drug Hypersensitivity |
23.3% |
| Vaginal Ulceration |
10.0% |
| Vulvovaginal Pain |
10.0% |
| Vaginal Haemorrhage |
6.7% |
| Vulvovaginal Burning Sensation |
6.7% |
| Vulvovaginal Pruritus |
6.7% |
| Abdominal Pain |
3.3% |
| Hypersensitivity |
3.3% |
| Nausea |
3.3% |
| Product Quality Issue |
3.3% |
| Renal Haemorrhage |
3.3% |
| Urticaria |
3.3% |
| Vaginal Disorder |
3.3% |
| Visual Impairment |
3.3% |
| Vulvovaginal Dryness |
3.3% |
| Vulvovaginal Mycotic Infection |
3.3% |
| Weight Decreased |
3.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.1% |
| Menopause |
8.5% |
| Pain |
6.8% |
| Breast Cancer Metastatic |
6.1% |
| Depression |
6.1% |
| Fungal Infection |
6.1% |
| Acne |
5.4% |
| Contraception |
4.4% |
| Anxiety |
4.1% |
| Hypertension |
4.1% |
| Premedication |
4.1% |
| Nausea |
3.7% |
| Vaginal Infection |
3.7% |
| Prophylaxis |
2.7% |
| Hypersensitivity |
2.4% |
| Cellulitis |
2.0% |
| Dermatitis Contact |
1.7% |
| Herpes Simplex |
1.7% |
| Sleep Disorder |
1.7% |
| Bone Disorder |
1.4% |
|
| Transposition Of The Great Vessels |
19.6% |
| Herpes Simplex |
10.9% |
| Vulvovaginal Mycotic Infection |
10.9% |
| Pulmonary Embolism |
8.7% |
| Breast Cancer |
4.3% |
| Oral Cavity Fistula |
4.3% |
| Skin Warm |
4.3% |
| Uterine Leiomyoma |
4.3% |
| Vaginal Infection |
4.3% |
| Vomiting |
4.3% |
| Weight Increased |
4.3% |
| Angioedema |
2.2% |
| Anhedonia |
2.2% |
| Arthralgia |
2.2% |
| Clostridium Difficile Colitis |
2.2% |
| Cough |
2.2% |
| Death |
2.2% |
| Deep Vein Thrombosis |
2.2% |
| Diabetic Vascular Disorder |
2.2% |
| Drug Exposure During Pregnancy |
2.2% |
|
